158 related articles for article (PubMed ID: 19007658)
21. Trypsins and their role in carcinoma growth.
Nyberg P; Ylipalosaari M; Sorsa T; Salo T
Exp Cell Res; 2006 May; 312(8):1219-28. PubMed ID: 16457812
[TBL] [Abstract][Full Text] [Related]
22. Endogenous inhibitors of angiogenesis: a historical review.
Ribatti D
Leuk Res; 2009 May; 33(5):638-44. PubMed ID: 19117606
[TBL] [Abstract][Full Text] [Related]
23. Suppression of angiogenic activity of sera from diabetic patients with non-proliferative retinopathy by compounds of herbal origin and sulindac sulfone.
Skopinski P; Szaflik J; Duda-Król B; Nartowska J; Sommer E; Chorostowska-Wynimko J; Demkow U; Skopinska-Rózewska E
Int J Mol Med; 2004 Oct; 14(4):707-11. PubMed ID: 15375605
[TBL] [Abstract][Full Text] [Related]
24. Molecular pathways of angiogenesis inhibition.
Tabruyn SP; Griffioen AW
Biochem Biophys Res Commun; 2007 Mar; 355(1):1-5. PubMed ID: 17276388
[TBL] [Abstract][Full Text] [Related]
25. Antiangiogenic antithrombin.
O'Reilly MS
Semin Thromb Hemost; 2007 Oct; 33(7):660-6. PubMed ID: 18000792
[TBL] [Abstract][Full Text] [Related]
26. Control of melanoma cell invasion by type IV collagen.
Pasco S; Brassart B; Ramont L; Maquart FX; Monboisse JC
Cancer Detect Prev; 2005; 29(3):260-6. PubMed ID: 15936594
[TBL] [Abstract][Full Text] [Related]
27. Chapter 15. Methods to study myeloid cell roles in angiogenesis.
Schmid MC; Varner JA
Methods Enzymol; 2008; 445():343-71. PubMed ID: 19022067
[TBL] [Abstract][Full Text] [Related]
28. Anti-angiogenic gene therapy of cancer: current status and future prospects.
Persano L; Crescenzi M; Indraccolo S
Mol Aspects Med; 2007 Feb; 28(1):87-114. PubMed ID: 17306361
[TBL] [Abstract][Full Text] [Related]
29. Targeting angiogenesis with compounds from the extracellular matrix.
Belotti D; Foglieni C; Resovi A; Giavazzi R; Taraboletti G
Int J Biochem Cell Biol; 2011 Dec; 43(12):1674-85. PubMed ID: 21864705
[TBL] [Abstract][Full Text] [Related]
30. Novel endogenous angiogenesis inhibitors and their therapeutic potential.
Rao N; Lee YF; Ge R
Acta Pharmacol Sin; 2015 Oct; 36(10):1177-90. PubMed ID: 26364800
[TBL] [Abstract][Full Text] [Related]
31. Angiogenesis: molecular mechanisms of activation, promotion and maintenance.
Bikfalvi A
J BUON; 2007 Sep; 12 Suppl 1():S59-66. PubMed ID: 17935279
[TBL] [Abstract][Full Text] [Related]
32. Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors.
Wang B; Sun J; Kitamoto S; Yang M; Grubb A; Chapman HA; Kalluri R; Shi GP
J Biol Chem; 2006 Mar; 281(9):6020-9. PubMed ID: 16365041
[TBL] [Abstract][Full Text] [Related]
33. Ligustrazine inhibits B16F10 melanoma metastasis and suppresses angiogenesis induced by Vascular Endothelial Growth Factor.
Chen L; Lu Y; Wu JM; Xu B; Zhang LJ; Gao M; Zheng SZ; Wang AY; Zhang CB; Zhang WW; Lei N
Biochem Biophys Res Commun; 2009 Aug; 386(2):374-9. PubMed ID: 19523924
[TBL] [Abstract][Full Text] [Related]
34. Molecular imaging of angiogenesis.
Neeman M; Gilad AA; Dafni H; Cohen B
J Magn Reson Imaging; 2007 Jan; 25(1):1-12. PubMed ID: 17139635
[TBL] [Abstract][Full Text] [Related]
35. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
[TBL] [Abstract][Full Text] [Related]
36. Novel approaches in anti-angiogenic treatment targeting endothelial F-actin: a new anti-angiogenic strategy?
Thoenes L; Günther M
Curr Opin Mol Ther; 2008 Dec; 10(6):579-90. PubMed ID: 19051136
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel short peptides derived from the alpha 4, alpha 5, and alpha 6 fibrils of type IV collagen with anti-angiogenic properties.
Karagiannis ED; Popel AS
Biochem Biophys Res Commun; 2007 Mar; 354(2):434-9. PubMed ID: 17239819
[TBL] [Abstract][Full Text] [Related]
38. Role of non-neuronal nicotinic acetylcholine receptors in angiogenesis.
Arias HR; Richards VE; Ng D; Ghafoori ME; Le V; Mousa SA
Int J Biochem Cell Biol; 2009 Jul; 41(7):1441-51. PubMed ID: 19401144
[TBL] [Abstract][Full Text] [Related]
39. Natural products as angiogenesis inhibitors.
Paper DH
Planta Med; 1998 Dec; 64(8):686-95. PubMed ID: 9933986
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo anti-angiogenic activities and inhibition of hormone-dependent and -independent breast cancer cells by ceramide methylaminoethylphosphonate.
Chintalapati M; Truax R; Stout R; Portier R; Losso JN
J Agric Food Chem; 2009 Jun; 57(12):5201-10. PubMed ID: 19476359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
